A pilot study of volumetric and density tumor analysis of ACC patients treated with vorinostat in a phase II clinical trial()

por Malarkey, Molly, Toscano, Alex P., Bagheri, Mohammad Hadi, Solomon, Jeffrey, Machado, Laura B., LoRusso, Patricia, Chen, Alice, Folio, Les R., Goncalves, Priscila H.
Publicado 2023

Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma

por Lurain, Kathryn, Ramaswami, Ramya, Mangusan, Ralph, Widell, Anaida, Ekwede, Irene, George, Jomy, Ambinder, Richard, Cheever, Martin, Gulley, James L, Goncalves, Priscila H, Wang, Hao-Wei, Uldrick, Thomas S, Yarchoan, Robert
Publicado 2021

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma

por Uldrick, Thomas S., Gonçalves, Priscila H., Wyvill, Kathleen M., Peer, Cody J., Bernstein, Wendy, Aleman, Karen, Polizzotto, Mark N., Venzon, David, Steinberg, Seth M., Marshall, Vickie, Whitby, Denise, Little, Richard F., Wright, John J., Rudek, Michelle A., Figg, William D., Yarchoan, Robert
Publicado 2017

A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma

por Goncalves, Priscila H., Heilbrun, Lance K., Barrett, Michael T., Kummar, Shivaani, Hansen, Aaron R., Siu, Lillian L., Piekarz, Richard L., Sukari, Ammar W., Chao, Joseph, Pilat, Mary Jo, Smith, Daryn W., Casetta, Lindsay, Boerner, Scott A., Chen, Alice, Lenkiewicz, Elizabeth, Malasi, Smriti, LoRusso, Patricia M.
Publicado 2017